Article Details
Retrieved on: 2022-12-09 15:06:10
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
(Alliance News) - AstraZeneca PLC on Thursday announced that datopotamab deruxtecan has shown "encouraging and durable efficacy" in phase 1 trials ...
Article found on: www.morningstar.co.uk
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here